Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.0610
0.00 (0.00%)
Sep 4, 2026, 4:00 PM EST
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $615.58 thousand as of September 8, 2026. Its market cap has decreased by -78.86% in one year.
Market Cap
615.58K
Enterprise Value
2.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
ChartMarket Cap Chart
Since October 15, 2020, Mosaic ImmunoEngineering's market cap has decreased from 1.69M to 615.58K, a decrease of -63.49%. That is a compound annual growth rate of -15.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 441.77K | -80.39% |
| Dec 31, 2025 | 2.25M | -55.65% |
| Dec 31, 2024 | 5.08M | 16.87% |
| Dec 29, 2023 | 4.35M | -39.39% |
| Dec 30, 2022 | 7.17M | -2.75% |
| Dec 31, 2021 | 7.37M | 181.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SQZ Biotechnologies Company | 707.79K |
| Halberd | 655.39K |
| inTerra Resources | 458.51K |
| Nextel Medical | 441.93K |
| Altamira Therapeutics | 405.80K |
| Actavia Life Sciences | 385.91K |
| Lyra Therapeutics | 354.98K |
| Sorrento Therapeutics | 326.23K |